Toward understanding cancer stem cell heterogeneity in the tumor microenvironment

TLDR

Cancer stem cells exist in heterogeneous subsets that occupy distinct tumor regions and display varied epithelial–mesenchymal phenotypes, posing a clinical challenge. The study aims to develop a theoretical framework to examine how the tumor microenvironment modulates spatial patterning of CSC subsets. The authors devise a theoretical model linking tumor‑microenvironment signals to spatial CSC distribution. The model shows that a gradient of EMT‑inducing signals together with Notch‑JAG1 signaling from inflammatory cytokines explains CSC spatial heterogeneity, and JAG1 knockdown in SUM149 organoids markedly limits tumor growth, confirming JAG1 as a therapeutic target.

Abstract

Significance The presence of heterogeneous subsets of cancer stem cells (CSCs) remains a clinical challenge. These subsets often occupy different regions in the primary tumor and have varied epithelial–mesenchymal phenotypes. Here, we devise a theoretical framework to investigate how the tumor microenvironment (TME) modulates this spatial patterning. We find that a spatial gradient of EMT-inducing signal, coupled with juxtacrine Notch-JAG1 signaling triggered by inflammatory cytokines in TME, explains this spatial heterogeneity. Finally, in vitro JAG1 knockdown in triple-negative breast cancer SUM149 cells severely restricts the growth of tumor organoid, hence validating the association between JAG1 and CSC fraction. Our results offer insights into principles of spatiotemporal patterning in TME and identify a relevant target to alleviate multiple CSC subsets: JAG1.